| Literature DB >> 28830236 |
Mahesh Kb Parmar1, Matthew R Sydes1, Fay H Cafferty1, Babak Choodari-Oskooei1, Ruth E Langley1, Louise Brown1, Patrick Pj Phillips1, Melissa R Spears1, Sam Rowley1, Richard Kaplan1, Nicholas D James2, Timothy Maughan3, Nicholas Paton1,4, Patrick J Royston1.
Abstract
There is real need to change how we do some of our clinical trials, as currently the testing and development process is too slow, too costly and too failure-prone often we find that a new treatment is no better than the current standard. Much of the focus on the development and testing pathway has been in improving the design of phase I and II trials. In this article, we present examples of new methods for improving the design of phase III trials (and the necessary lead up to them) as they are the most time-consuming and expensive part of the pathway. Key to all these methods is the aim to test many treatments and/or pose many therapeutic questions within one protocol.Entities:
Keywords: Multi-arm; basket; multi-stage; platform; randomised trials; umbrella
Mesh:
Year: 2017 PMID: 28830236 PMCID: PMC5700799 DOI: 10.1177/1740774517725697
Source DB: PubMed Journal: Clin Trials ISSN: 1740-7745 Impact factor: 2.486